Cargando…
Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator gene (CFTR) that result in diminished quantity and/or function of the CFTR anion channel. F508del-CFTR, the most common CF-causing mutation (found in ∼90% of patients), causes severe processing and trafficking...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571452/ https://www.ncbi.nlm.nih.gov/pubmed/31218221 http://dx.doi.org/10.1183/23120541.00082-2019 |